 |
|
 |
Enzyme Business sells enzymes on-line Novo Nordisk Enzyme Business has brought a whole new meaning to the abbreviation EB. Now it also stands for 'electronic business'. |
|
|
HRT alliance in the US Teaming up with Pharmacia Corporation Novo Nordisk aims to ensure sufficient sales power for a full blown marketing of its HRT products. Read more on page 2. |
|
Financial highlights Summary of the Group |
|
Financial
statement For the first half of 2000 |
|
A new US strategy Novo Nordisk has adopted a new strategy for the competitive US health care market. Partnerships will still be part of the strategy, but in diabetes the company will build on its own expertise. Read more on page 5. |
|
New managements Establishing two new, independent companies also means appointing two new management teams. Read more on page 6. |
 |
|
Two new managements
Establishing two new, independent companies also means appointing two new management teams.
The two companies Novozymes A/S and Novo Nordisk A/S will be led by management teams recruited from within the organisation. So although many of the faces are well known, we would like to present them here anyway due to the new roles they will play in their new companies.
Novozymes A/S
Steen RiisgaardPresident and chief executive officer (CEO)
Today Steen Riisgaard is a member of Novo Nordisk's Corporate Management with special responsibility for Enzyme Business. After the demerger he will be the president and CEO of Novozymes A/S.
Steen Riisgaard joined Novo in 1979 as a microbiologist in Enzymes R&D. In 1982, he went to Tokyo, Japan, to set up an Enzymes R&D unit in Novo's subsidiary Novo Industri Japan Ltd. He returned to Denmark in 1985 as director of Enzyme Process Research and was appointed vice president of the Detergent Enzyme Division the following year. In 1989 he was promoted to corporate executive vice president with special responsibility for the Enzyme Business, including Enzyme R&D, Enzyme Production, Enzyme Operations, and all of Novo Nordisk's activities in China.
Steen Riisgaard received his MSc (Biology) from the University of Copenhagen.
Per FalholtExecutive vice president and chief science officer (CSO)
Per Falholt is currently corporate vice president, Enzyme Business R&D. After the demerger he will be executive vice president and CSO of Novozymes A/S.
Per Falholt joined Novo in 1984 as a research chemist at the Enzyme R&D pilot plant. In 1987, he was appointed manager in the Detergent Enzyme Division. In 1990 he was appointed director responsible for application and development of new products for the detergent industry. In 1995 he joined the newly formed Enzyme Development and Applications (EDA) division as director for Application Technology II until he was posted to Raleigh, North Carolina, to run the US EDA unit in 1997. In 1999 he was appointed corporate vice president with responsibility for Enzyme Development and Application.
Effective 1 May 2000, he was appointed corporate vice president of Enzyme Business R&D.
Per Falholt received his MSc (Chemical Engineering) from the Technical University of Denmark (1983).
Per Månsson Executive vice president and chief financial officer (CFO)
Per Månsson is currently corporate vice president for Enzyme Economy, Logistics and Quality. After the demerger he will be executive vice president and CFO of Novozymes A/S with responsibility for Finance, IT and Legal.
Per Månsson joined Novo Nordisk in 1993 as director for Business Systems Development in Bioindustrial Group Finance. From 1994 to 1996 he was director, Economy, Systems & IT in Enzyme Production. From 1996 to 1998 he served as director for Economy, Purchasing & Customer Logistics and as a member of Enzyme Business Management, and in1999 he was appointed corporate vice president for Enzyme Economy, Logistics and Quality.
Per Månsson holds a Doctorate in Business Studies from the University of Umeå, Sweden (1983) and a BSc in Business Studies (1977) from the same university.
Peder Holk Nielsen Executive vice president,
Sales & Marketing
Today Peder Holk Nielsen is corporate vice president for Enzyme Business Operations. After the demerger he will be executive vice president, Sales & Marketing, Novozymes A/S.
Peder Holk Nielsen joined Novo Industri A/S in 1984 as an assistant product manager in the Enzymes Division. From 1985 to 1986 he served as product manager for new products/markets, Enzymes Division, and from 1986 as product manager, Enzyme Process Division. In 1987 he became manager, New Business Development Group, and was appointed director, New Business Development Group in 1988. In 1990 he was appointed vice president, Industrial Biotechnology, and in 1993 vice president, Research and Development, Enzyme Process Division. From December 1994 to December 1998 he served as corporate vice president for Enzyme Development and Applications. In 1996 Quality Management in Enzyme Business was added to his responsibilities. He was appointed corporate vice president, Enzyme Business Operations in January 1999.
Peder Holk Nielsen holds an MSc (Chemical Engineering) from the Technical University of Denmark (1981), where he also earned his PhD (Chemical Engineering) in 1984. He also holds a BCom (International Business Management) from the Copenhagen Business School (1985).
Arne W Schmidt
Executive vice president, Production and Procurement
Arne W Schmidt is currently corporate vice president, Enzyme Production. After the demerger he will be executive vice president, Production and Procurement, Novozymes A/S.
Arne W Schmidt joined Novo Terapeutisk Laboratorium in 1970 as a chemist in Enzyme Mixing. From 1980 to 1989 he served as head of production, Enzyme Finishing, and was appointed manager, Enzyme Finishing in 1989. In 1992 he was appointed director, Medical Systems Division, and became director, Diabetes Care Division in 1993. In 1995 he was appointed director, Medical Systems, Health Care Business, and in 1996 director, Diabetes Disposable Pens Management, Health Care Business. He was appointed to his present position in January 1997.
Arne W Schmidt holds a BSc (Chemical Engineering) from the Danish Academy of Engineering (1968).
